Following four highly successful in-person editions, this virtual conference will focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking optimized for our virtual platform.
Who should attend?: Faculty, postdocs, and graduate students interested in the techniques and applications of next generation cancer models at the intersection of cancer biology, engineering, and drug development.
Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies.